Medicare Enrolled
Dr. Daniel Robertshaw, M.D.
Urology Physician · Fairfield, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Robertshaw from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Robertshaw?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Robertshaw
Dr. Daniel Robertshaw is an urology physician in Fairfield, OH, with 18 years of NPI registration. Based on federal Medicare data, Dr. Robertshaw performed 3,008 Medicare services across 2,305 unique beneficiaries.
Between the years covered by Open Payments, Dr. Robertshaw received a total of $6,987 from 46 pharmaceutical and/or device companies across 362 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Robertshaw is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 18% volume in OH
$6,987 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,008
Medicare services
Top 18% in OH for urology physician
2,305
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~167 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
669 | $3 | $25 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
586 | $85 | $249 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
262 | $8 | $32 |
| PSA test (prostate cancer screening) | 233 | $18 | $71 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
194 | $46 | $206 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
101 | $5 | $37 |
| Blood urea nitrogen test A blood test that measures the amount of urea nitrogen to assess kidney function. |
100 | $4 | $29 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
96 | $55 | $625 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
73 | $59 | $206 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
72 | $7 | $94 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
72 | $108 | $391 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
61 | $8 | $52 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
52 | $18 | $85 |
| Tumor marker analysis A laboratory test that analyzes a sample to detect the presence of tumor markers. These markers are substances that may be found in the blood, urine, or body tissues. |
52 | $20 | $51 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
44 | $25 | $312 |
| Urine culture, bacterial identification A laboratory test that grows and identifies bacteria from a urine sample to detect infections. |
44 | $8 | $39 |
| Bacterial culture, aerobic A laboratory test that grows and identifies bacteria capable of surviving in oxygen. The results help determine the presence of specific aerobic microorganisms. |
36 | $8 | $105 |
| Antibiotic sensitivity test A laboratory test that determines which antibiotics, antifungals, or antivirals are effective against a specific microorganism using microdilution or agar dilution methods. |
35 | $8 | $105 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
34 | $64 | $468 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
27 | $101 | $316 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
26 | $96 | $525 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
24 | $94 | $1,243 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
18 | $62 | $148 |
| Cystourethroscopy with ureteroscopy or pyeloscopy A diagnostic procedure using an endoscope to examine the bladder, urethra, and ureter or kidney. |
17 | $225 | $1,234 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
15 | $25 | $101 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
15 | $16 | $85 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
14 | $310 | $2,305 |
| Surgical removal of prostate and lymph nodes This procedure involves the surgical removal of the prostate gland and surrounding lymph nodes using an endoscope. |
13 | $923 | $7,964 |
| Endoscopic removal of pelvic lymph nodes, bilateral A surgical procedure to remove lymph nodes from both sides of the pelvis using an endoscope. This minimally invasive technique involves making small incisions to access and excise the tissue. |
12 | $260 | $2,477 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
11 | $552 | $2,325 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.3% high complexity
4.7% medium
94.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,987
Total received (2018-2024)
Avg $998/year across 7 years
Top 24% in OH for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
362
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,458 (92.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$529 (7.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,006
2023
$911
2022
$1,309
2021
$1,225
2020
$653
2019
$651
2018
$1,232
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$170
Calyxo, Inc.
$153
ABBVIE INC.
$151
Janssen Biotech, Inc.
$125
Sumitomo Pharma America, Inc.
$98
PROCEPT BioRobotics Corporation
$48
COLOPLAST CORP
$46
Ferring Pharmaceuticals Inc.
$35
Dendreon Pharmaceuticals LLC
$35
PFIZER INC.
$32
Antares Pharma, Inc.
$24
Merck Sharp & Dohme LLC
$22
UROGEN PHARMA, INC.
$20
Axonics, Inc.
$19
ACCORD HEALTHCARE, INC.
$16
Olympus America Inc.
$13
Top 3 companies account for 47.1% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,390
Janssen Biotech, Inc.
$1,010
Boston Scientific Corporation
$526
Coloplast Corp
$348
COLOPLAST CORP
$278
Teleflex LLC
$275
TOLMAR Pharmaceuticals, Inc.
$239
PFIZER INC.
$212
Dendreon Pharmaceuticals LLC
$200
Intuitive Surgical, Inc.
$196
ABBVIE INC.
$185
Bayer HealthCare Pharmaceuticals Inc.
$162
Sumitomo Pharma America, Inc.
$159
BOSTON SCIENTIFIC CORPORATION
$158
Calyxo, Inc.
$153
Axonics Modulation Technologies, Inc.
$136
AbbVie, Inc.
$121
Bayer Healthcare Pharmaceuticals Inc.
$110
UroGen Pharma, Inc.
$104
Janssen Products, LP
$100
ACCORD HEALTHCARE, INC.
$87
UROVANT SCIENCES INC
$80
PROCEPT BioRobotics Corporation
$74
Myovant Sciences Inc.
$67
AbbVie Inc.
$57
Ferring Pharmaceuticals Inc.
$54
Merck Sharp & Dohme LLC
$49
UROGEN PHARMA, INC.
$48
Olympus America Inc.
$40
Antares Pharma, Inc.
$37
Medtronic, Inc.
$36
AstraZeneca Pharmaceuticals LP
$30
DENTSPLY IH Inc.
$28
Mission Pharmacal Company
$27
Amgen Inc.
$25
Clinigen Inc
$25
NeoTract Inc.
$23
Sun Pharmaceutical Industries Inc.
$22
Endo Pharmaceuticals Inc.
$19
Axonics, Inc.
$19
SUN PHARMACEUTICAL INDUSTRIES INC.
$16
Egalet US Inc
$15
Foundation Medicine, Inc.
$13
Progenics Pharmaceuticals, Inc.
$13
E.R. Squibb & Sons, L.L.C.
$12
Medtronic USA, Inc.
$11
Top 3 companies account for 41.9% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · ADVANCE · AMS 700 · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Androgel · Axonics · Axonics r-SNM System · BOTOX · BRIDION · CAMCEVI · CONTINENCE CARE · CVAC ASPIRATION SYSTEM · Da Vinci Surgical System · ELIGARD · ERLEADA · Erleada · FIRMAGON · FOUNDATIONONE · GEMTESA · GENERAL ERECTILE DYSFUNCTION · GENERAL ERECTILE DYSFUNCTION · General - Erectile Dysfunction · INTERSTIM · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LithoVue · LoFric · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · Nubeqa · ORGOVYX · Otrexup · PROVENGE · PYLARIFY · Proleukin · Prolia · Rezum Generator · SPEEDICATH · SPRIX · SpeediCath · TOVIAZ · UroLift · UroLift System · Urocit-K · XTANDI · XYOSTED · Xofigo · YONSA · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
87
Per 100K population
22.3
County median income
$81,194
Nearest hospital
MERCY HEALTH - FAIRFIELD HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Robertshaw is a clinical cardiology specialist, with above-average Medicare volume (top 18% in OH), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Robertshaw experienced with urinalysis, manual?
Based on Medicare claims data, Dr. Robertshaw performed 669 urinalysis, manual services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Robertshaw receive payments from pharmaceutical companies?
Yes. Dr. Robertshaw received a total of $6,987 from 46 companies across 362 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Robertshaw's costs compare to other urology physicians in Fairfield?
Dr. Robertshaw's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Robertshaw) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Fairfield
Browse urology physicians in Fairfield ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in OH
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in OH
Which OH urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology